End-of-Life Conversation Game for Cancer
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to determine if a conversation game called "Hello" can assist people with cancer and their loved ones in planning for end-of-life care. The study will assess whether the game requires modifications for cancer patients and how playing it influences hospital visits and medical decisions. Participants will either play "Hello for Cancer," which centers on cancer-related discussions, or a general conversation game called Table Topics. Individuals diagnosed with solid tumor cancers and receiving care at Penn State Health, or their chosen caregivers, might be suitable candidates. As an unphased trial, this study offers a unique opportunity to contribute to research that could enhance end-of-life planning for cancer patients and their families.
Do I have to stop taking my current medications for this trial?
The trial information does not specify whether you need to stop taking your current medications. It seems unlikely, as the study focuses on playing a conversation game rather than medical treatment.
What prior data suggests that the Hello for Cancer game is safe for individuals with cancer?
Research has shown that the Hello game provides a comfortable setting for discussing sensitive end-of-life topics. In studies with over 200 participants, the game proved easy to handle, with no reports of negative effects. It mainly helps people discuss their wishes and decisions for end-of-life care. As it is not a medical treatment, it does not carry the same risks as a drug or procedure. Participants found it engaging and useful for planning their care, indicating it is safe to play.12345
Why are researchers excited about this trial?
Researchers are excited about the Hello for Cancer game because it offers a unique approach to facilitating end-of-life conversations for individuals with cancer and their loved ones. Unlike traditional methods that might involve direct counseling or medical consultations, this game creates an interactive and engaging environment to explore complex topics around cancer experiences and medical decision-making. By encouraging open dialogue through thought-provoking questions, the game can help participants express their feelings and preferences in a less formal setting. This innovative method could lead to more meaningful discussions and better-informed decisions about end-of-life care.
What evidence suggests that the Hello for Cancer game is effective for advance care planning in cancer patients?
Research has shown that the Hello game aids people in planning future medical care. In previous studies, participants found it useful for discussing end-of-life care. This trial will test a modified version, the Hello for Cancer game, specifically with cancer patients. The game includes questions that encourage individuals to consider and share their health care preferences. Early results suggest it can make these challenging conversations easier and more approachable. Meanwhile, another arm of this trial will use the Table Topics game, which poses a variety of conversation-starting questions not specifically related to medical decision-making.13567
Who Is on the Research Team?
Lauren Van Scoy, MD
Principal Investigator
Penn State College of Medicine
Are You a Good Fit for This Trial?
This trial is for individuals with various solid cancers such as breast, lung, and colorectal cancer. Participants will be from Penn State Health clinics who are interested in advance care planning. They should be willing to answer questionnaires, play a game designed to facilitate end-of-life conversations, join a focus group discussion, and do a follow-up interview.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Participants play either the Hello for Cancer game or the Table Topics game, complete pre- and post-game questionnaires, and participate in focus groups.
Follow-up
Participants complete a telephone follow-up interview to assess ACP behaviors and satisfaction with the intervention.
Long-term Follow-up
The patient's medical chart is reviewed for up to two years to capture healthcare utilization and documentation of ACP discussions.
What Are the Treatments Tested in This Trial?
Interventions
- Hello for Cancer game
Find a Clinic Near You
Who Is Running the Clinical Trial?
Milton S. Hershey Medical Center
Lead Sponsor